🇺🇸 Dendritic cell vaccination in United States

25 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 25

Most-reported reactions

1. Death — 9 reports (36%)
2. Disease Progression — 6 reports (24%)
3. Type Iv Hypersensitivity Reaction — 3 reports (12%)
4. Cerebral Haemorrhage — 1 report (4%)
5. Cerebral Infarction — 1 report (4%)
6. Hypoxia — 1 report (4%)
7. Interstitial Lung Disease — 1 report (4%)
8. Metastases To Bone — 1 report (4%)
9. Metastases To Central Nervous System — 1 report (4%)
10. Metastases To Lymph Nodes — 1 report (4%)

Source database →

Frequently asked questions

Is Dendritic cell vaccination approved in United States?

Dendritic cell vaccination does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Dendritic cell vaccination in United States?

Baylor Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.